Levetiracetam 250mg Oral Solution from Canada
Sweetened oral solution at 250mg per dose for pediatric and geriatric epilepsy treatment. Falls under HTS 3004.90.92.41 for its prophylactic CNS anticonvulsant use in retail measured forms.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Stability testing for light-sensitive solutions mandatory
• Metered-dose packaging required for accuracy
• Avoid alcohol-containing formulations if prohibited for certain markets